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Abstract 
This paper presents a review of a dog, with a retrobulbar chondrosarcoma, which was admitted for surgery for 
visible changes in his eye during inspection. Orbital neoplasia in dogs may be primary and secondary. Sixty percent 
of orbital neoplasia in dogs are primary, ninety percent of which are malignant. Retrobulbar neoplasms are rare and 
in their early stage represent a diagnostic challenge. Chondrosarcoma of the skull is a slow-progressing malignant 
disease which occurs locally, aggressive with invasion into the surrounding tissues. Dogs with chondrosarcoma of 
the skull have life expectancy between 210 and 580 days - in our case it was 180 days - after the first alterations on 
the eye of the dog occurred. 
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Introduction 
Chondrosarcoma (CS) is a malignant tumour of bones 
in animals and humans. This neoplasm corresponds to 
5 - 10% of all the primary bone tumours in dogs. 
Primary CS may occur on skeletal system and then it 
is called central or medular CS. When CS is located 
on periosteum, it is called peripheral CS (Withrow and 
Vail, 2007). 
Case Details 
Eight years and seven months old male Cocker 
Spaniel was admitted to the surgery for presence of a 
thick mucus discharge and changes on the cornea of 
his left eye. The dog apparently did not have any other 
health issues. During the clinical examination, the dog 
was fit, in a good mood and there were no changes in 
regional lymph nodes. The changes on the left eye 
were visible: presence of the dried mucus discharge 
and clingy hair on the upper eyelid and medial 
canthus.  
Due to protrusion of the eye bulb, a pronounced 
exophthalmos of the left eye was clearly perceptible. 
The upper lateral quadrant of the cornea was blurry. 
There were no visible changes in the right eye.  
The methods used during the first examination of the 
eye were: the fluorescein eye stain test, the Schirmer I 
tear test, measurement of the intraocular pressure and 
the Jones’ test for patency of nasolacrimal duct. As the 
process progressed, the tumour was sampled for 
histopathological examination and computed 
tomography of the skull was also performed in the 
follow-up examinations.  
The intraocular pressure was measured by the Schiotz 
method, with prior application of anaesthetic 
(proparacain) to the eye. The solution of fluorescein 
was used for staining the cornea and testing the 
patency of the nasolacrimal duct. The computed 
tomography of the skull was performed by the third-
generation device GE (9800-8800), under sedation 
using Domitor.  
The inspection revealed changes on the auxiliary parts 
of the left eye and presence of dried mucus discharge. 
Alopecia was not noticed on the lids of the left eye. 
The third eyelid protruded out of its place covering 
half of the eye bulb (Fig. 1).  
 
 
 
Fig. 1. Dried mucous secretion on the eye lids, hyperaemia, 
oedema of the conjunctiva with protrusion of the third eye 
lid and keratitis (one month after the first examination). 
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The dog did not react painfully to retropulsion of the 
eye bulb, which was performed due to its enlargement. 
There was no counter effect from the bottom of the 
orbit of the affected eye during the retropulsion. The 
Schirmer I test results for the right and the left eye 
were 15 mm and 6 mm, respectively. There was a 
superficial whitish blur in the upper medial quadrant 
of the left eye cornea.   
The fluorescein stain test was positive, which 
indicated alteration of the superficial layer of the 
cornea. The Jones’ test was positive for both 
nasolacrimal ducts.  The changes on the iris and on the 
anterior chamber were not noticed during the 
ophthalmoscopy. Examination of the posterior 
segment of the eye and the lens of the left eye was 
performed after application of the Midriacil 1% drops 
to the eye. A central Y nuclear sclerosis was noticed in 
the lens.  
There were no anatomic deviations on the fundus, 
both on the tapetal and non-tapetal part of the retina. A 
slight swelling of the optic papilla was observable. 
The mean values of the intraocular pressure of the 
right eye and the left eye were 22.38 mmHg and 10.24 
mmHg, respectively.  
The findings of the examination, absence of tears, 
moderate exophthalmos and slight protrusion of the 
third eye lid were basis for establishing the working 
diagnosis of keratoconjunctivitis sicca of the left eye, 
so further regular follow-ups were advised. The 
therapy for dry eye (artificial tears) and systemic 
antibiotic therapy (Cephalexin tabl. 15 mg/kg) were 
administered to the dog.   
A month later, the next examination revealed 
significant deterioration of the clinical signs on the 
surface of the cornea and significant enlargement of 
the eye bulb (Fig. 2).  
 
 
Fig. 2. Lateral transposition of the left bulb and 
impossibility of retropulsion of the left eye to the orbit. 
Dried secretion on the left nostril. 
The position of the left eye bulb indicated upward 
lateral strabismus. The third eye lid was everted and 
the conjunctiva was swollen. When performed again, 
the Jones’ test resulted with absence of staining in the 
left nostril which indicated obstruction of the left 
nasolacrimal duct.  
The owner reported that the dog sniffles discharging a 
thick secretion from the left nostril and has 
swallowing problems. Computed tomography of the 
skull with prior application of sedative Domitor 
followed the examination of the mouth cavity, which 
revealed an obvious tumoural mass behind the last 
upper molar on the left side.  
The scan was performed in dorsolateral position    
(Fig. 3).  
 
 
Fig. 3. Computed tomography of the skull. The left eye bulb 
protrusion, presence of the tumoural mass in the very base of 
the orbit with osteolysis of the nasal septum and presence of 
the neoplasm in the left nasal duct. 
 
 
The images clearly showed presence of the neoplasia 
in the region of the medial orbit, osteolysis of the 
nasal septum and presence of the tumoural mass in the 
left nasal duct (Fig. 4 and 5).  
 
 
Fig. 4. Reconsturction: neoplasia the bottom of the orbit. 
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Fig. 5. Reconstruction: the neoplasia affects the bottom of 
the orbit and osteolysis of part of the orbit. 
 
The excisional biopsy of the neoplasm in the mouth 
cavity with prior application of xylocain 2% spray was 
performed after the scan (Fig. 6).  
 
 
Fig. 6. Position of the prominent part of the tumour behind 
the last molar of the maxilla. 
 
The system therapy including antibiotic and NSAID – 
antibiotic Cephalexin at a dose of 15 mg/kg p/o and 
Movalis tablets at a dose of 1.7 mg/kg BW per day – 
was applied, as the dog obviously suffered from pain. 
The excised tumour was assessed morpho-
pathologically.  
The tumoral mass was 3, 4x2, 5x1.8 cm in size and 
25g in weight and hard in texture (Fig. 7).  
 
 
Fig. 7. The part of the tumour removed for histopathological 
examination. 
The preparation for histopathological examination was 
dyed with hematoxylin and eosin (H&E). 
Histopathological findings showed presence of 
pleomorphic cells with vesicular nucleus containing 
one or more nucleoli. The tumour cells produced the 
chondroid matrix and they were arranged, by their 
shape and size, in irregular groups which were 
separated from the surrounding tissue (Fig. 8).  
 
 
Fig. 8. Depicted scattered pleomorphic binuclear 
chondrocytes. Clearly pronounced cytoplasm, due to the 
larger amount of glycogen. The isles of hyaline cartilage 
surrounded by non-defined mesenchymal cells (H&E x300). 
 
Such histopathological finding indicated a highly 
differentiated mesenchymal sarcoma of the left eye 
with destruction of the nasal septum.  
Since surgery and radical removal of the neoplasm, as 
well as application of chemotherapy, were not 
possible, the dog was given the medication for pain 
relief and the eye was treated locally with the 
antibiotic drops (Tobramicin 4x1). Three months after 
the final diagnosis was established, the dog died. 
Discussion 
Primary neoplasia of the orbit can arise from any 
tissue: epithelial, vascular, nervous or connective 
tissue. Secondary orbital neoplasia arises from the 
nasal structures, sinuses or cranial cavities of the skull 
and rarely as distant metastasis. Meningioma, 
lymphosarcoma, adenocarcinoma, fibrosarcoma, 
myxoma, glioma, squamous cell carcinoma (SCC) and 
rabdomyosarcoma are among the numerous neoplasia 
of the orbit in dogs.  
In dogs, 90% of orbital tumors are malignant. CS 
occurs on pelvis, facial bones, ribs, vertebrae and 
scapula as a non-painful tumoural mass (Bostock and 
Owen, 1975). The occurrence in trachea, lungs, 
omentum, mammary gland, heart valves, aorta, 
tongue, root of the penis and the penile urethra was 
also reported (Kim et al., 2007).  
CS is a malignant tumour cells which produce 
cartilaginous matrix. It develops from the cartilage 
structures of the bones and can also develop out of the 
tissues where cartilage normally does not exist. CS of 
the skull rarely occurs and most often, in 28.8% cases, 
it can be found in the nasal cavity, 9% of which is on 
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the facial bones (maxilla, mandible and orbit) (Kim et 
al., 2007).  
Due to impossibility of the eye closure, the cornea 
gets dry and keratitis, conjunctivitis, myosis and 
eccentric pupil can be observed. The eye affected by 
CS of the orbit is non-functional, and due to 
destruction of the nasal septum and expansion of the 
tumor, a thick nasal discharge, difficult breathing and 
nasal stridor are also present.  
Besides the clinical signs, ultrasonography of the eye 
and the orbit, fine-needle aspiration biopsy (FNA), 
plain radiography of the skull, computed tomography 
and magnetic resonance imaging (MRI) are also the 
methods used in diagnosing CS of the orbit. Regarding 
the differential diagnosis, CS should be distinguished 
from non-neoplastic inflammatory orbital granuloma, 
cellulitis and abscesses and from myositis of 
extraocular muscles and masticatory muscles.  
The main symptom in the dogs with inflammatory 
processes in the region of the orbit is presence of a 
strong pain during mouth opening. The dogs with 
inflammatory processes in the region of the orbit feel 
pain during mouth opening (Withrow and Vail, 2007).  
The following six parameters are being used in CT 
scan and in diagnosis of tumours of the nose, the 
superior sinuses and the orbit: 
1. Bilateral expansion of the tumour in basal 
and paranasal sinuses. 
2. Destruction of the nasal bone and finding of 
tumoural mass on nasal surface and in the 
facial area. 
3. Presence of the tumour in the mouth cavity 
with hard palate destruction. 
4. Presence of the tumour in the orbit and lateral 
pressure on the bulb. 
5. The frontal sinus involvement. 
6. The brain involvement and destruction of the 
cranium, expansion of the tumour into the 
brain (Kondo et al., 2008). 
Radiography reveals presence of the irregular and 
often blurred areas permeated by calcification. 
Atypical cartilaginous tissue with metachromatic basal 
material can be observed in the histopathological 
finding. Some cells and some groups of cells are 
binuclear. Especially characteristic are the big atypical 
cells with large “swollen-plump” nuclei (Zlateva and 
Milenkov, 1983). All degrees of differentiation occur; 
benign tumours have an abundant cartilaginous matrix 
whilst malignant tumours contain closely packed cells 
with plump, frequently multiple nuclei. Mitotic figures 
are common in the more malignant tumours (Bostock 
and Owen, 1975).  
Sometimes, calcifications and ossifications can be 
found in the cartilaginous tissue of the tumour. 
Treatment for CS of the skull is directly dependent on 
its localization and the degree of invasiveness towards 
the surrounding tissue. As it is a malignant tumour, the 
treatment of choice, if it is possible, would be the 
surgery.  
Orbitotomy with resection of zygomatic arch is 
recommended. If the tumoural mass is small, a 
transconjuctival approach to the tumour is also 
possible (Maggs et al., 2008). In the case of the 
surgery, the operation is difficult because 
differentiation between the normal and the tumoural 
tissue is not easy.  
For this reason, it can happen that the neoplasm is 
removed incompletely, which causes consequent 
recurrences (Gelatt and Gelatt, 2011). In the case that 
the tumour invaded the brain, the mouth cavity, or the 
orbit, radiotherapy – either as monotherapy or 
combined with chemotherapy – and sometimes (as it 
was in our case) even only the antibiotic and NSAID 
treatment are recommended before the surgical 
treatment.  
Prognosis for the orbital tumours is poor since the 
surgical treatment does not solve the issue of 
recurrences. The dogs with orbital osteolysis (as in our 
case) have even poorer prognosis. In the case of 
radical surgery (orbitectomy), the owners are reluctant 
to accept the fact that their pet is going to have the 
postoperative facial deformity. The studies suggest 
that surgical treatment of CS and chemotherapy can 
prolong life of the dog for six months (Gelatt 
and Gelatt, 2011). The average life expectancy for 
dogs with CS that also invaded the nasal cavity is 
between 210 and 580 days, with treatment provided 
(rhinotomy with radiotherapy) (Withrow and Vail, 
2007). The low-grade chodrosarcoma can grow for a 
long time during several years without showing a 
tendency to metastasize, while the fast-growing CS 
metastasizes to lungs, kidneys, liver and heart 
(Withrow and Vail, 2007).  
CS of the orbit is a rare, slow-progressing malignant 
disease in dogs and is extremely destructive to 
surrounding tissues. In the cases of clinically 
diagnosed CS in dogs, the dogs were in the age of 
about eight years. On the computed tomography scans 
one can observe a large, irregularly shaped mass with 
destruction of the orbital bones and mineralisation of 
the tumoural matrix. There is also compression of the 
local tissue, the muscles of the eye bulb and 
dislocation of the eye bulb from the orbit.  
Due to the difficult approach to the tumour and the 
pronounced destruction of the surrounding tissues, it is 
difficult to perform the surgery. Recurrences are very 
frequent and the life expectancy in dogs is less than a 
year after the accurate diagnosis is established. Due to 
the severe pain, it is necessary to apply the potent 
NSAID and opioid analgesics as well as the 
supportive therapy including vitamins and intravenous 
solutions to bring some relief to the dog.  
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